| 000 | 01830cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223031011.0 | ||
| 008 | 140618s2013 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.19.03.Ph.D.2013.He.P | ||
| 100 | 0 | _aHeba Allah Elsayed Abdelrhman | |
| 245 | 1 | 0 |
_aPrognostic significance of nucleophosmin gene (NPM1) mutations in acute myeloid leukemia / _cHeba Allah Elsayed Abdelrhman ; Supervised Hussein Moustafa Khaled , Ragia Hussein Badawy , Ayman Mohamed Metwally |
| 246 | 1 | 5 | _aأثر إختلال النيكلوفوسمين جين على المسار المرضى لمرضى السرطان الميلودى الحاد |
| 260 |
_aCairo : _bHeba Allah Elsayed Abdelrhman , _c2013 |
||
| 300 |
_a226 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - National Cancer Institute - Department of Clinical Pathology | ||
| 520 | _aThe remarkable molecular heterogeneity of acute myeloid leukemia (AML) has made a genetic - based classification, essential for accurate diagnosis, prognostic stratification, monitoring minimal residual disease, and developing targeted therapies. NPM1 mutations represent the most frequent alterations in AML, occurring in approximately one third of adult patients with AML, and are associated with a normal karyotype | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute myeloid leukemia | |
| 653 | 4 | _aNPM1 gene | |
| 653 | 4 | _aNucleophosmin gene | |
| 700 | 0 |
_aAyman Mohamed Metwally , _eSupervisor |
|
| 700 | 0 |
_aHussein Moustafa Khaled , _eSupervisor |
|
| 700 | 0 |
_aRagia Hussein Badawy , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c46337 _d46337 |
||